イスラエル - ヘブライ語 - Ministry of Health

sanofi israel ltd - zolpidem tartrate - טבליות מצופות פילם - zolpidem tartrate 10 mg - zolpidem - zolpidem - indications are limited to treatment of severe sleep disorders in the following cases: - occasional insomnia - transient insomnia.

イスラエル - ヘブライ語 - Ministry of Health

taro international ltd, israel - triamcinolone acetonide - פסטה - triamcinolone acetonide 0.1 % - triamcinolone - triamcinolone - indicated for the adjunctive treatment and the temporary relief of symptoms associated with oral inflammatory and ulcerative lesions.

イスラエル - ヘブライ語 - Ministry of Health

teva medical ltd - calcium chloride dihydrate; dextrose hydrous; lactic acid as sodium; magnesium chloride hexahydrate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - lactic acid as sodium 448 mg / 100 ml; magnesium chloride hexahydrate 5.08 mg / 100 ml; calcium chloride dihydrate 25.7 mg / 100 ml; sodium chloride 538 mg / 100 ml; dextrose hydrous 1.5 g / 100 ml - combinations - combinations - indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis.

イスラエル - ヘブライ語 - Ministry of Health

teva medical marketing ltd. - glucose monohydrate; potassium chloride; sodium chloride - תמיסה להזרקה - sodium chloride 0.45 g / 100 ml; potassium chloride 0.224 g / 100 ml; glucose monohydrate 5 g / 100 ml - combinations of electrolytes - combinations of electrolytes - indicated for replenishing water, electrolytes and calories .

イスラエル - ヘブライ語 - Ministry of Health

megapharm ltd - imiquimod - קרם - imiquimod 5 % - imiquimod - imiquimod - indicated for the topical treatment of external genital and perianal warts (condyloma acuminata) in adult patients. for the treatment of actinic keratoses in adults with normal immune systems. for the treatment of superficial basal cell carcinoma in adults with normal immune systems when surgical methods are less appropriate.

イスラエル - ヘブライ語 - Ministry of Health

taro pharmaceutical industries ltd - imiquimod - קרם - imiquimod 5 % - imiquimod - imiquimod - indicated for the topical treatment of external genital and perianal warts (condyloma acuminata) in adult patients. for the treatment of actinic keratoses in adults with normal immune systems. for the treatment of superficial basal cell carcinoma in adults with normal immune systems when surgical methods are less appropriate.

イスラエル - ヘブライ語 - Ministry of Health

perrigo israel pharmaceuticals ltd - imiquimod - קרם - imiquimod 5 % - imiquimod - imiquimod - indicated for the topical treatment of external genital and perianal warts (condyloma acuminata) in adult patients. for the treatment of actinic keratoses in adults with normal immune systems. for the treatment of superficial basal cell carcinoma in adults with normal immune systems when surgical methods are less appropriate.

イスラエル - ヘブライ語 - Ministry of Health

organon pharma israel ltd., israel - betamethasone acetate; betamethasone sodium phosphate - תרחיף להזרקה - betamethasone acetate 3 mg/ml; betamethasone sodium phosphate 3.945 mg/ml - betamethasone - betamethasone - indicated in the management of conditions known to be responsive to corticosteroid therapy.

イスラエル - ヘブライ語 - Ministry of Health

teva israel ltd - tenofovir disoproxil as fumarate - טבליות מצופות פילם - tenofovir disoproxil as fumarate 245 mg - tenofovir disoproxil - tenofovir disoproxil - indicated for the treatment of : 1. hiv 1 infected adults and pediatric patients 12 years of age and older in combination with other antiretroviral medicinal products for the treatment of hiv.2. chronic hepatitis b in adults with: • compensated liver disease, with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active inflammation and/or fibrosis. • decompensated liver disease.

イスラエル - ヘブライ語 - Ministry of Health

novartis israel ltd - topotecan as hydrochloride - קפסולות ג'לטין קשיחות - topotecan as hydrochloride 0.25 mg - topotecan - topotecan - indicated for the treatment of patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate.